PRESS RELEASE
FOR IMMEDIATE RELEASE
Male Breast Cancer Global Alliance and BardDiagnostics Launch 2025 Pilot Screening Program for Rescue Servicemen
New York, NY – September 29, 2025 – The Male Breast Cancer Global Alliance (MBCGA), in partnership with BardDiagnostics, today announced the official launch of its 2025 Pilot Screening Program for Early Detection of Male Breast Cancer designed specifically for the rescue service community. This initiative marks a historic step in addressing the heightened cancer risks faced by firefighters, EMTs, law enforcement, and other frontline rescue personnel due to occupational exposures.
Dr. Robert L. Bard, internationally recognized diagnostic imaging specialist and early detection advocate, first joined the MBCGA in 2018. Since then, he has delivered private screenings for hundreds of men through his Second Opinion Scan and Fight Recurrence programs. Building upon this foundation, the new partnership transforms years of individual services into the first coordinated screening program officially dedicated to the rescue service sector.
Addressing a Critical Need
Studies and firsthand reports from across the U.S. have confirmed that rescue servicemen are disproportionately affected by male breast cancer and other cancers. This elevated risk stems from chronic exposures to toxins such as smoke, soot, fuel byproducts, and chemical agents encountered in the line of duty. In recent years, the MBCGA has tracked a growing number of cases among firefighters and first responders, highlighting the urgent need for proactive health measures.
“The rescue community faces daily risks most of us cannot imagine,” said Cheri Ambrose, Co-Founder and President of MBCGA. “Our alliance has seen firsthand the rising number of breast cancer cases linked to these exposures. This program is more than a pilot – it is a promise to provide the tools of early detection to those who protect us.”
The Screening Program
The 2025 pilot will begin in New York City, offering state-of-the-art ultrasound screening and diagnostic imaging conducted by BardDiagnostics. The program will provide:
-
Free baseline screenings for eligible rescue service members.
-
Access to advanced 3D Doppler ultrasound imaging, a non-invasive tool proven effective in detecting early signs of tumors.
-
Educational outreach on occupational cancer risks and the importance of routine monitoring.
-
Confidential follow-up consultations for men flagged for further evaluation.
Screenings are supported by donors of the AngioInstitute’s educational initiatives, ensuring participants also receive guidance on next steps, prevention strategies, and available clinical care pathways.
Leadership Perspective: “Launching this program is the culmination of years of advocacy and science,” said Dr. Robert Bard, Diagnostic Director of BardDiagnostics. “We’ve learned that occupational exposures play a direct role in breast cancer cases among men in the rescue service. Early detection is our strongest weapon. By providing rescue workers with imaging access now, we can save lives before disease progresses.”
A Public Service Partnership: The program reflects the MBCGA’s mission to expand awareness, improve survivorship, and fight the stigma surrounding male breast cancer. By partnering with BardDiagnostics, the Alliance ensures that frontline heroes are not only recognized for their sacrifices but also given proactive access to life-saving care.
The 2025 pilot will serve as a model for future national rollouts, with plans to expand screenings to additional firehouses, EMS stations, and police departments across the country.
Call to Action: The Male Breast Cancer Global Alliance invites public and private partners, civic leaders, and healthcare organizations to join this groundbreaking initiative. Together, we can build a national framework of protection and prevention for those who risk their lives daily.
For more information, or to schedule a screening, visit www.mbcglobalalliance.org or contact cheri@mbcglobalalliance.org.
About the Male Breast Cancer Global Alliance (MBCGA):
The MBCGA is a worldwide advocacy organization dedicated to raising awareness, providing education, and advancing research into male breast cancer. The Alliance unites survivors, clinicians, researchers, and advocates to dismantle stigma, accelerate early detection, and support men and families affected by this rare but devastating disease.
About BardDiagnostics:
Founded by Dr. Robert L. Bard, BardDiagnostics is a New York-based clinical practice specializing in advanced diagnostic imaging for cancer detection and recurrence monitoring. Known as a leader in ultrasound, 3D Doppler, and image-guided diagnostics, BardDiagnostics has pioneered early detection programs for high-risk groups, including first responders and military veterans.
No comments:
Post a Comment